GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » Tariff Resilience Score

Univo Pharmaceuticals (XTAE:UNVO-M) Tariff Resilience Score : 0/10 (As of Jul. 19, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals Tariff Resilience Score?

Univo Pharmaceuticals has the Tariff Resilience Score of 0, which implies that the company might have .

Univo Pharmaceuticals has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Univo Pharmaceuticals might have .


Univo Pharmaceuticals  (XTAE:UNVO-M) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Univo Pharmaceuticals Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Univo Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Harshar 20, Ashkelon, ISR, 7878329
Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines